Regina Won is an Infectious Disease physician affiliated with Legacy Mount Hood Medical Center. OpenAlex indexes 10 publications with 264 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
24800 SE Stark St Fl 3
Legacy Medicine Inpatient Service
Gresham, OR 97030
Telephone
503-674-1122Registry record last updated 15 May 2018.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Integra LifeSciences CorporationProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
92.9%First-generation cephalosporins26.2%Cephalexin100%Part D<11 patientsCephalosporin Antibacterial17.5%Ceftriaxone59%Cefazolin Sodium41%Part D<11 patients+ 5 more classes in this area
Cardiovascular
7.1%Cholesterol absorption inhibitor7.1%Ezetimibe100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- P-2160. Where Does Karius Testing Have a Clinical Impact? A Retrospective Analysis of Next Generation Sequencing
Open Forum Infectious Diseases
2025 - 294. Interim Analysis of an Evidence-Based Bundle Intervention for Uncomplicated Enterobacterales Bacteremia
Open Forum Infectious Diseases
2020 - Review and Validation of Bayesian Dose‐Optimizing Software and Equations for Calculation of the Vancomycin Area Under the Curve in Critically Ill Patients
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
2018 - Prospective evaluation of vancomycin pharmacokinetics in a heterogeneous critically ill population
Diagnostic Microbiology and Infectious Disease
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Yousef Khader
Jordan University of Science and Technology
Andrew Rambaut
University of Edinburgh
Olayinka Stephen Ilesanmi
University College Hospital
Maysaa El Sayed Zaki
Mansoura University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”